Similar Search Results

Three essays in medical cost-effectiveness analysis

Basu, Anirban - 2004

Persistent link: https://www.econbiz.de/10003383658

Estimating person-centered treatment (PeT) effects using instrumental variables

Basu, Anirban - 2012

Persistent link: https://www.econbiz.de/10009547239

Estimating Person-Centered Treatment (PeT) effects using instrumental variables : an application to evaluating prostate cancer treatments

Basu, Anirban - In: Journal of applied econometrics 29 (2014) 4, pp. 671-690

Persistent link: https://www.econbiz.de/10010414862

Implications of spillover effects within the family for medical cost-effectiveness analysis

Basu, Anirban; Meltzer, David - In: Journal of health economics 24 (2005) 4, pp. 751-773

Persistent link: https://www.econbiz.de/10002937889

Returns to pharmaceutical innovation in the market for oral chemotherapy in response to insurance coverage expansion

Bennette, Caroline S.; Basu, Anirban; Ramsey, Scott; … - 2017

Persistent link: https://www.econbiz.de/10011743344

Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion

Bennette, Caroline S. - 2017

We estimated the average returns, in terms of patient survival, to the marginal innovations in oral chemotherapy market induced by Part D expansion of oral chemotherapy coverage for elderly individuals by mandating inclusion of "all or substantially all" oral anti-cancer medications on plans'...

Persistent link: https://www.econbiz.de/10012453869

Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion

Bennette, Caroline - 2017

We estimated the average returns, in terms of patient survival, to the marginal innovations in oral chemotherapy market induced by Part D expansion of oral chemotherapy coverage for elderly individuals by mandating inclusion of “all or substantially all” oral anti-cancer medications on...

Persistent link: https://www.econbiz.de/10012947011